99 related articles for article (PubMed ID: 29873512)
1. Proteostasis as a therapeutic target in glomerular injury associated with mutant α-actinin-4.
Yee A; Papillon J; Guillemette J; Kaufman DR; Kennedy CRJ; Cybulsky AV
Am J Physiol Renal Physiol; 2018 Oct; 315(4):F954-F966. PubMed ID: 29873512
[TBL] [Abstract][Full Text] [Related]
2. Glomerular epithelial cell injury associated with mutant alpha-actinin-4.
Cybulsky AV; Takano T; Papillon J; Bijian K; Guillemette J; Kennedy CR
Am J Physiol Renal Physiol; 2009 Oct; 297(4):F987-95. PubMed ID: 19640905
[TBL] [Abstract][Full Text] [Related]
3. Ubiquitin C-terminal hydrolase L1 deletion ameliorates glomerular injury in mice with ACTN4-associated focal segmental glomerulosclerosis.
Read NC; Gutsol A; Holterman CE; Carter A; Coulombe J; Gray DA; Kennedy CR
Biochim Biophys Acta; 2014 Jul; 1842(7):1028-40. PubMed ID: 24662305
[TBL] [Abstract][Full Text] [Related]
4. FSGS-associated alpha-actinin-4 (K256E) impairs cytoskeletal dynamics in podocytes.
Michaud JL; Chaisson KM; Parks RJ; Kennedy CR
Kidney Int; 2006 Sep; 70(6):1054-61. PubMed ID: 16837921
[TBL] [Abstract][Full Text] [Related]
5. Mice with podocyte-specific overexpression of wild type alpha-actinin-4 are healthy controls for K256E-alpha-actinin-4 mutant transgenic mice.
Michaud JL; Stitt-Cavanaugh E; Endlich N; Endlich K; De Repentigny Y; Kothary R; Kennedy CR
Transgenic Res; 2010 Apr; 19(2):285-9. PubMed ID: 19585264
[TBL] [Abstract][Full Text] [Related]
6. Focal and segmental glomerulosclerosis in mice with podocyte-specific expression of mutant alpha-actinin-4.
Michaud JL; Lemieux LI; Dubé M; Vanderhyden BC; Robertson SJ; Kennedy CR
J Am Soc Nephrol; 2003 May; 14(5):1200-11. PubMed ID: 12707390
[TBL] [Abstract][Full Text] [Related]
7. Alpha-actinin-4 and CLP36 protein deficiencies contribute to podocyte defects in multiple human glomerulopathies.
Liu Z; Blattner SM; Tu Y; Tisherman R; Wang JH; Rastaldi MP; Kretzler M; Wu C
J Biol Chem; 2011 Sep; 286(35):30795-30805. PubMed ID: 21680739
[TBL] [Abstract][Full Text] [Related]
8. Modulating alpha-actinin-4 dynamics in podocytes.
Michaud JL; Hosseini-Abardeh M; Farah K; Kennedy CR
Cell Motil Cytoskeleton; 2009 Mar; 66(3):166-78. PubMed ID: 19206166
[TBL] [Abstract][Full Text] [Related]
9. Podocyte Injury Associated with Mutant α-Actinin-4.
Cybulsky AV; Kennedy CR
J Signal Transduct; 2011; 2011():563128. PubMed ID: 21808733
[TBL] [Abstract][Full Text] [Related]
10. Pdlim2 is a novel actin-regulating protein of podocyte foot processes.
Sistani L; Dunér F; Udumala S; Hultenby K; Uhlen M; Betsholtz C; Tryggvason K; Wernerson A; Patrakka J
Kidney Int; 2011 Nov; 80(10):1045-54. PubMed ID: 21814175
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of ACTN4 Leads to Podocyte Vulnerability and Proteinuric Glomerulosclerosis.
Feng D; Kumar M; Muntel J; Gurley SB; Birrane G; Stillman IE; Ding L; Wang M; Ahmed S; Schlondorff J; Alper SL; Ferrante T; Marquez SL; Ng CF; Novak R; Ingber DE; Steen H; Pollak MR
J Am Soc Nephrol; 2020 Jul; 31(7):1479-1495. PubMed ID: 32540856
[TBL] [Abstract][Full Text] [Related]
12. Disease-causing mutation in α-actinin-4 promotes podocyte detachment through maladaptation to periodic stretch.
Feng D; Notbohm J; Benjamin A; He S; Wang M; Ang LH; Bantawa M; Bouzid M; Del Gado E; Krishnan R; Pollak MR
Proc Natl Acad Sci U S A; 2018 Feb; 115(7):1517-1522. PubMed ID: 29378953
[TBL] [Abstract][Full Text] [Related]
13. Discovery of new glomerular disease-relevant genes by translational profiling of podocytes in vivo.
Grgic I; Hofmeister AF; Genovese G; Bernhardy AJ; Sun H; Maarouf OH; Bijol V; Pollak MR; Humphreys BD
Kidney Int; 2014 Dec; 86(6):1116-29. PubMed ID: 24940801
[TBL] [Abstract][Full Text] [Related]
14. α-Actinin 4 potentiates nuclear factor κ-light-chain-enhancer of activated B-cell (NF-κB) activity in podocytes independent of its cytoplasmic actin binding function.
Zhao X; Hsu KS; Lim JH; Bruggeman LA; Kao HY
J Biol Chem; 2015 Jan; 290(1):338-49. PubMed ID: 25411248
[TBL] [Abstract][Full Text] [Related]
15. Cytoskeleton Rearrangements Modulate TRPC6 Channel Activity in Podocytes.
Shalygin A; Shuyskiy LS; Bohovyk R; Palygin O; Staruschenko A; Kaznacheyeva E
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33922367
[TBL] [Abstract][Full Text] [Related]
16. Podocytes exhibit a specialized protein quality control employing derlin-2 in kidney disease.
Ren G; Tardi NJ; Matsuda F; Koh KH; Ruiz P; Wei C; Altintas MM; Ploegh H; Reiser J
Am J Physiol Renal Physiol; 2018 Mar; 314(3):F471-F482. PubMed ID: 29167172
[TBL] [Abstract][Full Text] [Related]
17. Patients with ACTN4 mutations demonstrate distinctive features of glomerular injury.
Henderson JM; Alexander MP; Pollak MR
J Am Soc Nephrol; 2009 May; 20(5):961-8. PubMed ID: 19357256
[TBL] [Abstract][Full Text] [Related]
18. Podocyte expression of nonmuscle myosin heavy chain-IIA decreases in idiopathic nephrotic syndrome, especially in focal segmental glomerulosclerosis.
Miura K; Kurihara H; Horita S; Chikamoto H; Hattori M; Harita Y; Tsurumi H; Kajiho Y; Sawada Y; Sasaki S; Igarashi T; Kunishima S; Sekine T
Nephrol Dial Transplant; 2013 Dec; 28(12):2993-3003. PubMed ID: 24042022
[TBL] [Abstract][Full Text] [Related]
19. Endoplasmic reticulum stress in glomerular epithelial cell injury.
Cybulsky AV; Takano T; Papillon J; Kitzler TM; Bijian K
Am J Physiol Renal Physiol; 2011 Sep; 301(3):F496-508. PubMed ID: 21159733
[TBL] [Abstract][Full Text] [Related]
20. Focal and segmental glomerulosclerosis in murine models: a histological and ultrastructural characterization with immunohistochemistry correlation of glomerular CD44 and WT1 expression.
Husain S; Ginawi I; Bashir AI; Kfoury H; Al Johani TE; Hagar H; Raddaoui L; Al Ghonaim M; Alsuwaida A
Ultrastruct Pathol; 2018; 42(5):430-439. PubMed ID: 30285525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
